The novel and selective insulin-like growth factor-1 receptor kinase inhibitor PQIP suppresses bone cell function and osteoclast-breast cancer cell cross-talk in vitro

J. G. Logan, E. Landao-Bassonga, V. G. Brunton, A. I. Idris

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)S43-S43
Number of pages1
JournalBone
Volume48
Issue number1
DOIs
Publication statusPublished - 1 Jan 2011
Externally publishedYes
Event10th International Conference on Cancer - Induced Bone Disease - Sheffield
Duration: 22 Sep 201025 Sep 2010

Cite this